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Antibiotic resistance is a global problem with some predicting a return to the pre antibiotic 
era where a bacterial infection was commonly fatal. Pseudomonas aeruginosa is one example 
of this problem. This bacterium is a major cause of infection especially in cystic fibrosis 
sufferers and in burns victims. The rising rates of adverse outcomes are partly a consequence 
of strains commonly displaying multi-drug resistance (MDR) profiles. MDR is driven by a 
number of intrinsic mechanisms in P. aeruginosa clinical isolates as well as by the capture of 
diverse resistance-mediating genes by Lateral Gene Transfer (LGT). LGT and intrinsic 
factors often act cooperatively to generate complex MDR phenotypes. While these complex 
interactions have been examined in a small number of isolates there has not been a 
comprehensive survey of strains on a global scale. Thus it is not clear what mechanisms and 
genes may be important in influencing the evolution of MDR at regional or global levels. 
Also, in some isolates, resistance profiles cannot always be explained by identifying the 
common resistance determining pathways, suggesting that additional mechanisms of 
resistance may be emerging in P. aeruginosa. The focus of this project was to 
comprehensively study the major mechanisms responsible for antibiotic resistance in P. 
aeruginosa strains from diverse geographical areas. 
 
Pathogenic P. aeruginosa isolates from four countries (Australia and three South American 
countries) were characterized by PCR to identify mobile elements and their genetic context. 
Also, quantitative expression analysis for activity of several pathways that influence 
antibiotic resistance was assessed and culture experiments were conducted to test how 
?
random movement of mobile elements during growth may influence resistance to some 
antibiotics. 
 
 Data presented in this thesis indicated that, in most strains, antibiotic resistance was being 
driven by changes in multiple pathways (including overexpression of AmpC and two efflux 
pumps) and by the presence or absence of genes acquired by Lateral Gene Transfer (LGT). 
Class 1 integrons, elements important in the spread of antibiotic resistance genes in Gram-
negative bacteria, were most frequently recovered in South American countries. Many class 1 
integrons were mapped to a specific location within the genome. Regardless of country of 
origin all these mapped integrons were found to be in the chromosome, often in Genomic 
islands, and not on a plasmid despite data in the literature implying the opposite. The 
association of class 1 integrons with genomic islands may be an important mechanism 
driving LGT in P. aeruginosa. Also, a newly emerging mechanism involving the insertion 
sequence IS26 was identified that is capable of mobilizing resistance and other genes. This 
IS26-mediated mechanism may allow phenotype switching in clonal lines in a way that is 
likely to further exacerbate the treatment of infections mediated by P. aeruginosa. 
 
Data presented here suggested that P. aeruginosa strains are evolving to become multidrug 
resistant in increasingly complex ways. This is occurring by single strains acquiring changes 
in numerous known pathways as well as by newly emerging resistance mechanisms in this 
species.  
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